[1]
Taís Fries, A. et al. 2026. Evaluation of the presence of polymorphic forms and influence on the dissolution profile of Tenoxicam in active pharmaceutical ingredient and formulations . Drug Analytical Research. 2, 2 (Mar. 2026), 27–36. DOI:https://doi.org/10.22456/2527-2616.90005.